LendingTree, Inc. TREE 深 沪
等待开盘 04-02 09:30:00 美东时间
42.21
-0.670
-1.56%
华盛通- 最 高43.65
- 今 开42.87
- 成交量 17.66万股
- 最 低 42.13
- 昨 收 42.88
- 总市值 5.85亿
- 52周最高 77.345
- 市盈率 静 3.92
- 换手率 1.27%
- 52周最低 32.6487
- 委 比 67.09%
- 总股本 1385.58万
- 历史最高 434.94
- 量 比 0.96
- 振 幅 3.54%
- 历史最低 4.64
- 每 手 1
- 风险率 11.40%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多美股大行评级 | 7家上调，3家下调！CrowdStrike绩后大行评级现分歧；罗斯百货、塔吉特、Viking获多家大行上调目标价
今日重点评级关注：古根海姆：维持Dianthus Therapeutics"买入"评级，目标价从100美元升至200美元；HC Wainwright & Co.：维持Amylyx Pharmaceuticals"买入"评级，目标价从28美元升至34美元
03-05 13:56
美股牛股 | 获埃森哲12亿美元收购旗下Ookla，ZD飙升超48%；普拉格能源大涨超23%
获埃森哲12亿美元收购旗下 Ookla，ZD暴涨超48%；Q4亏损收窄收入增长17%，普拉格能源大涨超23%>>
03-04 16:24
美股大行评级 | 绩后暴跌超22%，MongoDB遭14家大行集团下调目标价；挪威邮轮、阿莎娜、Quantum Computing等也遭大行下调目标价
今日重点评级关注：HC Wainwright & Co.：维持NRX Pharmaceuticals"买入"评级，目标价从40美元升至45美元；RBC Capital：维持NUVATION BIO"跑赢大市"评级，目标价从12美元升至13美元
03-04 10:22
Needham Maintains Buy on LendingTree, Lowers Price Target to $60
Needham analyst Mayank Tandon maintains LendingTree (NASDAQ:TREE) with a Buy and lowers the price target from $85 to $60.
03-03 19:42
LendingTree shares are trading higher after the company reported better-than-expected Q4 sales results and issued FY26 and Q1 sales guidance above estimates.
LendingTree shares are trading higher after the company reported better-than-ex...
03-03 05:37
LendingTree Q4 Earnings Assessment
LendingTree (NASDAQ:TREE) reported its Q4 earnings results on Monday, March 2, ...
03-03 05:23
LendingTree Sees Q1 Sales $317.000M-$325.000M vs $279.172M Est
LendingTree (NASDAQ:TREE) sees Q1 sales of $317.000 million-$325.000 million vs $279.172 million analyst estimate.
03-03 05:21
LendingTree Sees FY2026 Sales $1.275B-$1.330B vs $1.164B Est
LendingTree (NASDAQ:TREE) sees FY2026 sales of $1.275 billion-$1.330 billion vs $1.164 billion analyst estimate.
03-03 05:21
LendingTree Q4 Adj. EPS $(0.39) Misses $0.87 Estimate, Sales $319.700M Beat $286.487M Estimate
LendingTree (NASDAQ:TREE) reported quarterly losses of $(0.39) per share which missed the analyst consensus estimate of $0.87 by 144.83 percent. This is a 133.62 percent decrease over earnings of $1.16 per share from the
03-03 05:19
Earnings Scheduled For March 2, 2026
Companies Reporting Before The Bell • Zymeworks (NASDAQ:ZYME) is expected to re...
03-02 19:11
